Latest News in the pharma Industry

Top Stories

UAE Reduces Drug Prices to Encourage Health Investment

UAE Reduces Drug Prices to Encourage Health Investment

15 Nov 2011

The UAE Ministry of Health has reduced the prices of 115 drugs in the country to support the partnership strategies between the department and local and international pharmaceutical companies.

Read more 
Bend Research & Merck Sign License Agreement

Bend Research & Merck Sign License Agreement

15 Nov 2011

Under the agreement, Oregon-based Bend Research will provide Merck with access to its proprietary spray dried dispersion (SDD) technology.

Read more 
WHO Praises UK for Flu Pandemic Preparedness

WHO Praises UK for Flu Pandemic Preparedness

14 Nov 2011

The World Health Organization has praised the UK for being one of the best prepared countries for future flu pandemics.

Read more 
Daiichi & ArQule Ink License Pact for Cancer Compound

Daiichi & ArQule Ink License Pact for Cancer Compound

14 Nov 2011

ArQule and Daiichi Sankyoa have announced their license agreement for the development of new AKT inhibitor ARQ 092.

Read more 
Lundbeck & Otsuka Ink Development Pact

Lundbeck & Otsuka Ink Development Pact

14 Nov 2011

The alliance is a sales and cost share agreement. Under the terms of the agreement, Lundbeck will make an upfront payment upon signing of USD 200 million (approximately DKK 1.1 billion).

Read more 
Baxter Completes Baxa Acquisition

Baxter Completes Baxa Acquisition

11 Nov 2011

Baxter International has completed the acquisition of Baxa Corporation for a cash consideration of $380 million.

Read more 
Teva to Make Jobcuts across US and Europe

Teva to Make Jobcuts across US and Europe

11 Nov 2011

Teva is to make 1,000 of its employees redundant following its acquisition of US-based Cephalon last month.

Read more 
Ablynx & Merck Serono Expand Partnership into Osteoarthritis

Ablynx & Merck Serono Expand Partnership into Osteoarthritis

10 Nov 2011

Ablynx and Merck Serono have entered into a third agreement to co-discover and co-develop Nanobodies against two targets in osteoarthritis.

Read more 
Salix Takes over Oceana Therapeutics for $300M

Salix Takes over Oceana Therapeutics for $300M

10 Nov 2011

Salix Pharmaceuticals is paying $300 million in cash to acquire Oceana Therapeutics, a provider of gastroenterology and urology therapeutics.

Read more 
Pfizer to Keep on 650 Jobs at UK R&D Facility

Pfizer to Keep on 650 Jobs at UK R&D Facility

9 Nov 2011

Pfizer decides to keep on 650 staff at its R&D centre in Kent, UK, following an announcement to close the facility earlier this year.

Read more 
Bayer Anti-clotting Drug Wins FDA Approval

Bayer Anti-clotting Drug Wins FDA Approval

8 Nov 2011

Bayer Healthcare's anti-clotting drug Xarelto has won FDA approval to treat stroke in people with an abnormal heart rhythm.

Read more 
DKSH and Hanseo Chemical Ink Pact for GPC

DKSH and Hanseo Chemical Ink Pact for GPC

8 Nov 2011

DKSH has signed a global exclusive agreement to distribute Hanseo Chemical's glycerophosphatidylcholin.

Read more